The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
Official Title: Randomised Phase 2 Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
Study ID: NCT01858662
Brief Summary: To analyze the pathological tumor response on resected colorectal cancer metastases after preoperative treatment with cetuximab combined with FOLFOX or FOLFIRI regimen in a prospective cohort (RAS and B-RAF WT tumors) and to correlate this response with patient's outcome.
Detailed Description: This is a phase II , openlabel, randomized study in patients with confirmed diagnosis of potentially or borderline resectable metastatic colorectal adenocarcinoma (RAS and B-RAF WT tumors ), who have not received prior chemotherapy for their metastatic disease. The study is designed to compare pathological responses observed after pre-operative chemotherapy cetuximab with FOLFOX or FOLFIRI.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Grand Hôpital de Charleroi, Charleroi, Hainaut, Belgium
clinique Saint Luc, Bouge, , Belgium
Cliniques universitaires Saint-Luc - UCL, Brussels, , Belgium
Centre Hospitalier Jolimont Lobbes, La Louvière, , Belgium
CHU liège (Sart Timan), Liège, , Belgium
Clinique Saint Pierre Ottignies, Ottignies, , Belgium
CHU-UCL Dinant-Godinne, Yvoir, , Belgium
Name: Marc Van den Eynde, MD
Affiliation: Cliniques universitaires Saint-Luc - UCL
Role: PRINCIPAL_INVESTIGATOR
Name: Javier Carrasco, MD PhD
Affiliation: Grand Hôpital de Charleroi
Role: PRINCIPAL_INVESTIGATOR